... and two others were indicted in May on federal charges stemming from a failed plan to build a biotechnology plant in northern Vermont using money ...
News
- Arrival of F-35 fighter jets was Vermont's top story of 2019
- Seattle Genetics Announces Submission of Tucatinib New Drug Application to the US FDA for ...
HER2CLIMB trial results were presented on December 11, 2019 at the 2019 San Antonio Breast Cancer Symposium and published in the New ...
- Blood testing nears a turning point as the evidence becomes undeniable
At this month's San Antonio Breast Cancer Symposium, Epic presented two research studies of people with metastatic or triple-negative disease, ...
- Puma Biotechnology, Inc. (PBYI) on Focus After Crashing In Today's Session
Puma Biotechnology, Inc. (PBYI) on Focus After Crashing In Today's ... It increased, as 20 investors sold Puma Biotechnology, Inc. shares while 23 ... San Antonio Breast Cancer Symposium – Business Wire” on December 11, 2019, ...
- Moleculin Announces New Data Shows Reversal of Tumor Activity in Animal Models
"Importantly, the published poster, which can be found on our web site at https://www.moleculin.com/san-antonio-bc-symposium-poster/, shows ...